NewAmsterdam Pharma Company N.V. Stock BOERSE MUENCHEN
Stocks
KH6
NL00150012L7
Biotechnology & Medical Research
|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 26.42 EUR | -1.97% |
|
-0.99% | -8.95% |
| Market Cap | 3.14B 3.58B 2.92B 2.68B 5.04B 344B 5.11B 34.69B 13.55B 169B 13.43B 13.14B 585B | P/E 2026 * |
-17.2x | P/E 2027 * | -20.5x |
|---|---|---|---|---|---|
| Enterprise Value | 2.74B 3.12B 2.55B 2.34B 4.39B 300B 4.46B 30.25B 11.82B 148B 11.71B 11.46B 511B | EV / Sales 2026 * |
120x | EV / Sales 2027 * | 19.6x |
| Free-Float |
99.09% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: NewAmsterdam Pharma Company N.V.
| 1 week | -0.99% | ||
| Current month | -9.29% | ||
| 1 month | -1.96% | ||
| 3 months | -0.04% | ||
| 6 months | -5.11% | ||
| Current year | -8.95% |
| 1 week | 26 |  | 28.2 |
| 1 month | 26 | | 32.31 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Davidson
CEO | Chief Executive Officer | 69 | 2022-10-31 |
Mayur Somaiya
DFI | Director of Finance/CFO | 52 | 2023-10-22 |
Douglas Kling
COO | Chief Operating Officer | 53 | 2021-02-28 |
| Director | Title | Age | Since |
|---|---|---|---|
Michael Davidson
BRD | Director/Board Member | 69 | 2022-10-31 |
John Kastelein
BRD | Director/Board Member | 72 | 2022-10-31 |
James Topper
BRD | Director/Board Member | 64 | 2022-10-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.97% | -0.99% | +32.11% | - | 3.57B | |
| -1.92% | -1.57% | +48.70% | +84.37% | 55.92B | |
| +0.93% | +7.22% | +64.67% | +63.56% | 56.67B | |
| -2.15% | -2.02% | -21.77% | -16.26% | 23.28B | |
| -0.77% | -1.20% | +3.38% | +423.04% | 23.28B | |
| -0.36% | -0.56% | +36.00% | -3.93% | 20.54B | |
| -1.34% | -0.63% | +29.60% | -32.53% | 17.78B | |
| -1.44% | -1.63% | +37.07% | +589.93% | 15.9B | |
| -1.30% | -9.92% | +160.67% | +284.37% | 14.64B | |
| +0.33% | -0.68% | +24.00% | +179.24% | 13.99B | |
| Average | -0.91% | +1.09% | +41.44% | +174.64% | 26.89B | |
| Weighted average by Cap. | -0.78% | +1.89% | +43.24% | +137.11% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 22.79M 25.95M 21.2M 19.45M 36.54M 2.5B 37.11M 252M 98.33M 1.23B 97.41M 95.32M 4.25B | 133M 151M 124M 113M 213M 14.56B 216M 1.47B 573M 7.16B 568M 555M 24.76B |
| Net income | -191M -218M -178M -163M -306M -20.96B -311M -2.11B -825M -10.3B -817M -799M -35.62B | -165M -188M -154M -141M -265M -18.11B -269M -1.82B -713M -8.9B -706M -691M -30.79B |
| Net Debt | -402M -458M -374M -343M -644M -44.07B -654M -4.44B -1.73B -21.66B -1.72B -1.68B -74.91B | -538M -613M -500M -459M -863M -59.01B -876M -5.94B -2.32B -29.01B -2.3B -2.25B -100B |
| Date | Price | Change |
|---|---|---|
| 26-07-24 | €26.42 | -1.97% |
| 26-07-23 | €26.95 | -3.27% |
| 26-07-22 | €27.86 | -1.21% |
| 26-07-21 | €28.20 | +8.17% |
| 26-07-20 | €26.07 | -6.19% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- NAMS Stock
- KH6 Stock
Select your edition
All financial news and data tailored to specific country editions
